Insulet
PODD
#1133
Rank
HK$158.56 B
Marketcap
HK$2,253
Share price
-1.31%
Change (1 day)
7.95%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): HK$27.23

According to Insulet's latest financial reports the company's current EPS (TTM) is HK$27.28. In 2024 the company made an earnings per share (EPS) of HK$46.60 an increase over its 2023 EPS that were of HK$22.99.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$27.23-41.57%
2024HK$46.60102.71%
2023HK$22.994114.29%
2022HK$0.55-69.57%
2021HK$1.79109.09%
2020HK$0.86-38.89%
2019HK$1.40200%
2018HK$0.47-113.04%
2017-HK$3.58-9.8%
2016-HK$3.97-60.47%
2015-HK$10.0538.71%
2014-HK$7.2512.05%
2013-HK$6.47-23.15%
2012-HK$8.42-12.2%
2011-HK$9.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ICU Medical
ICUI
-HK$2.42-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$23.77-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$14.42-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.36 198.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.79 130.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$28.91 6.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$159.90 486.24%๐Ÿ‡บ๐Ÿ‡ธ USA